The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 EnvelopeMark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al.|The Journal of Immunology|2012Cited by 140
Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut MicrobiomeOrnella Sortino, Putida Saetun, Alexandra M. Ortiz et al.|Open Forum Infectious Diseases|2019Cited by 37